Austin D. Kim

Companies

• Acadia PharmaceuticalsGeneral counsel Jul 20, 2018 to Jan 9, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APAcadia Pharmaceuticals ACAD46,901 shares²$919.7K at $19.61Jan 8, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 8, 2024Sold 590 shares at $29.96 of Acadia Pharmaceuticals²
• Jan 6, 2024Exercised options 1,634 shares of Acadia Pharmaceuticals²
• Oct 6, 2023Sold 16,369 shares at $21.96 of Acadia Pharmaceuticals³
• Oct 5, 2023Exercised options 36,174 shares of Acadia Pharmaceuticals³
• May 1, 2023Sold 917 shares at $21.18 of Acadia Pharmaceuticals⁴
• Apr 29, 2023Exercised options 3,005 shares of Acadia Pharmaceuticals⁴
• Apr 6, 2023Sold 1,456 shares at $18.16 of Acadia Pharmaceuticals⁵
• Apr 5, 2023Exercised options 4,773 shares of Acadia Pharmaceuticals⁵
• Feb 24, 2023Sold 803 shares at $18.78 of Acadia Pharmaceuticals⁶
• Feb 23, 2023Exercised options 2,214 shares of Acadia Pharmaceuticals⁶
• Jan 9, 2023Sold 589 shares at $17.13 of Acadia Pharmaceuticals⁷
• Jan 6, 2023Exercised options 1,633 shares of Acadia Pharmaceuticals⁷
• May 2, 2022Sold 894 shares at $18.18 of Acadia Pharmaceuticals⁸
• Apr 29, 2022Exercised options 3,005 shares of Acadia Pharmaceuticals⁸
• Feb 23, 2022Sold 782 shares at $23.80 of Acadia Pharmaceuticals⁹
• Feb 23, 2022Exercised options 2,213 shares of Acadia Pharmaceuticals⁹
• Jan 6, 2022Sold 574 shares at $23.05 of Acadia Pharmaceuticals¹⁰
• Jan 6, 2022Exercised options 1,633 shares of Acadia Pharmaceuticals¹⁰